Entact Biosciences
United States · $81.0M raised
- Website
- entactbio.com
- Total Funding
- $81.0M
- Last Round
- $81.0M Series ADec 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Entact Bio is a preclinical biotechnology company developing precision medicines that enhance beneficial protein function. Its ENTAC medicines use molecular matchmakers to recruit deubiquitylase enzymes and restore, relocate, or modify target proteins. The company's Encompass platform identifies targets, validates disease hypotheses, and designs target-specific ENTACs to address genetic disorders, complex diseases, and previously undruggable pathways.
Summary
Entact Biosciences is a Biotech company based in United States. It has raised $81.0M in total across 1 round, most recently a $81.0M Series A round in Dec 2022. Investors include Qiming Venture Partners USA and venBIO Partners.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2022
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/entact-biosciences"><img src="https://indexed.vc/api/badge/company/entact-biosciences" alt="Entact Biosciences on Indexed.vc" width="260" height="76" /></a>